| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMA/225000/2013 (16.04.13) |
| Publication Date | 16/04/2013 |
| Content Type | News |
|
The European Medicines Agency (EMA) will provide advice on the impact on public health and animal health of the use of antibiotics in animals. The request was made by the European Commission as part of its ‘Action Plan against the rising threats from Antimicrobial Resistance (AMR)’. The EMA’s Committee for Medicinal Products for Veterinary Use (CVMP) and the Committee for Medicinal Products for Human Use (CHMP) will work together in providing the Agency’s advice, which is expected to provide a sound scientific basis to inform decisions on the way in which antibiotics are used in animals. The advice will have input from the European Centre for Disease Prevention and Control (ECDC) and the European Food Safety Authority (EFSA). The group will also call on additional expertise as required to address the range of questions to be answered, underlining the multi-sectorial approach to tackling antimicrobial resistance. |
|
| Source Link | Link to Main Source http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/04/news_detail_001764.jsp&mid=WC0b01ac058004d5c1 |
| Related Links |
|
| Subject Categories | Business and Industry, Health |
| Countries / Regions | Europe |
